High-dose aprotinin in cardiac surgery: Three years' experience in 1,784 patients
- 1 June 1992
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 6 (3) , 324-327
- https://doi.org/10.1016/1053-0770(92)90150-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypassThe Annals of Thoracic Surgery, 1991
- Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial RevascularizationAnesthesiology, 1990
- High-Dose Aprotinin: Hemostatic Effects in Open Heart OperationsThe Annals of Thoracic Surgery, 1989
- Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical PatientsThe Thoracic and Cardiovascular Surgeon, 1989
- Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary ResultsThe Thoracic and Cardiovascular Surgeon, 1989
- Pilot Study on Quality Assurance in Cardiac SurgeryThe Thoracic and Cardiovascular Surgeon, 1988
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985